Interactions between quercetin and warfarin for albumin binding: A new eye on food/drug interference

Chirality

Volumn 22, Issue 6, 2010, Pages 593-596

  Di Bari, Lorenzo ^a   Ripoli, Silvia ^a   Pradhan, Sanghamitra ^a   Salvadori, Piero ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Circular dichroism; Drug albumin binding; Flavonoids; Human serum albumin; STD NMR

Indexed keywords

HUMAN SERUM ALBUMIN; IBUPROFEN; QUERCETIN; WARFARIN;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; DRUG PROTEIN BINDING; FOOD DRUG INTERACTION; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANTIOXIDANTS; CIRCULAR DICHROISM; DIETARY SUPPLEMENTS; FOOD-DRUG INTERACTIONS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; QUERCETIN; SERUM ALBUMIN; WARFARIN;

EID: 77951533737     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20794     Document Type: Article

References (18)

1. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S. Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 2005;353:38-52. (Pubitemid 41338838)
2. Boulton DW, Walle UK, Walle T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J Pharm Pharmacol 1998;50:243-249. (Pubitemid 28102584)
3. Dufour C, Dangles O. Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. Biochim Biophys Acta 2005;1721:164-173. (Pubitemid 40093524)
4. Banerjee A, Basu K, Sengupta PK. Interaction of 7-hydroxyflavone with human serum albumin: a spectroscopic study. J Photochem Photobiol B Biol 2008;90:33-40.
5. Di Bari L, Ripoli S, Salvadori P. Serum albumin and natural products. In: Palyi G, Zucchi C, Caglioti L, editors. Progress in biological chirality. Oxford, UK: Elsevier; 2004. p 271-295.
6. Kaldas MI, Walle UK, Van Der Woude H, Mcmillan JM, Walle T. Covalent binding of the flavonoid quercetin to human serum albumin. J Agric Food Chem 2005;53:4194-4197. (Pubitemid 40936783)
7. Kanakis CD, Tarantilis PA, Polissiou MG, Diamantoglou S, Tajmir-Riahi HA. Antioxidant flavonoids bind human serum albumin. J Mol Struct 2006;798:69-74. (Pubitemid 44485687)
8. Martini S, Bonechi C, Rossi C. Interaction of quercetin and its conjugate quercetin 3-O-b-D-glucopyranoside with albumin as determined by NMR relaxation data. J Nat Prod 2008;71:175-178. (Pubitemid 351362973)
9. Sengupta B, Sengupta PK. Binding of quercetin with human serum albumin: a critical spectroscopic study. Biopolymers 2003;72:427-434. (Pubitemid 37413220)
10. Zsila F, Bikadi Z, Simonyi M. Probing the binding of the flavonoid, quercetin to human serum albumin by circular dichroism, electronic absorption spectroscopy and molecular modelling methods. Biochem Pharmacol 2003;65:447-456. (Pubitemid 36084562)
11. Harborne JB, Mabry TJ, Mabry H, editors. The flavonoids. London: Chapman and Hall; 1975.
12. Harbord H, Harborne JB. The flavonoids advances in research since 1986. London: Chapman and Hall; 1993.
13. Zsila F, Bikadi Z, Fitos I, Simonyi M. Probing protein binding sites by circular dichroism spectroscopy. Curr Drug Discovery Technol 2004; 1:133-153.
14. Berova N, Di Bari L, Pescitelli G. Application of electronic circular dichroism in configurational and conformational analysis of organic compounds. Chem Soc Rev 2007;36:914-931.
15. Mayer M, Meyer B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc 2001;123:6108-6117. (Pubitemid 32888480)
16. Ascoli GA, Domenici E, Bertucci C. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality 2006;18:667-679. (Pubitemid 44408409)
17. Anslyn EV, Dougherty DA. Modern physical organic chemistry. Sausalito, CA: University Science Books; 2004.
18. Harder S, Thurmann P. Clinically important drug interactions with anticoagulants - an update. Clin Pharmacokinet 1996;30:416-444. (Pubitemid 26175753)